Activity of Temocillin against KPC-Producing Klebsiella pneumoniae and Escherichia coli

No abstract is available for this paper.

• Publication year

  2009

• Venue

  Antimicrobial Agents and Chemotherapy

• Publication date

  2009-03-30

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1128/AAC.00290-09PMID 19332667PMCID PMC2687206
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• In vitro activity of tigecycline against multidrug-resistant Enterobacteriaceae isolates from a Belgian hospital

  2009influential reference
• In vitro pharmacodynamics of colistin against multidrug-resistant Klebsiella pneumoniae.

  2008influential reference
• Carbapenem-resistant Escherichia coli harboring Klebsiella pneumoniae carbapenemase beta-lactamases associated with long-term care facilities.

  2008cited by this paper
• Treatment of Recurrent Urosepsis with Tigecycline: a Pharmacological Perspective

  2008cited by this paper
• Carbapenemases: the versatile beta-lactamases.

  2007cited by this paper
• Carbapenemases: the Versatile β-Lactamases

  2007cited by this paper
• In vitro activity of temocillin against prevalent extended-spectrum beta-lactamases producing Enterobacteriaceae from Belgian intensive care units

  2007cited by this paper
• Performance standards for antimicrobial disk susceptibility tests : approved standard

  2006cited by this paper
• In vitro activity of temocillin against extended spectrum beta-lactamase-producing Escherichia coli.

  2006cited by this paper
• Activity of temocillin against prevalent ESBL- and AmpC-producing Enterobacteriaceae from south-east England.

  2006cited by this paper
• BRL 17421, a novel beta-lactam antibiotic, highly resistant to beta-lactamases, giving high and prolonged serum levels in humans

  1981cited by this paper
• BRL 17421 , a Novel f ,-Lactam Antibiotic , Highly Resistant to , 8-Lactamases , Giving High and Prolonged Serum Levels in Humans

  year unknowninfluential reference

• Susceptibility Studies of Novel Antimicrobial Drugs Against Carbapenem-Resistant and Hypervirulent Klebsiella pneumoniae.

  2026cites this paper
• Pharmacokinetic/pharmacodynamic optimization of temocillin treatment against CTX-M-15-producing Klebsiella pneumoniae isolates in a hollow-fiber infection model

  2025cites this paper
• Evaluation of temocillin efficacy against KPC-2-producing Klebsiella pneumoniae isolates in a hollow-fibre infection model

  2024cites this paper
• Temocillin Resistance in the Enterobacter cloacae Complex Is Conferred by a Single Point Mutation in BaeS, Leading to Overexpression of the AcrD Efflux Pump

  2023cites this paper
• Carbapenem-Resistant Klebsiella pneumoniae: Virulence Factors, Molecular Epidemiology and Latest Updates in Treatment Options

  2023cites this paper
• An Overview of Antimicrobial Stewardship Optimization: The Use of Antibiotics in Humans and Animals to Prevent Resistance

  2022cites this paper
• Assessing Clinical Potential of Old Antibiotics against Severe Infections by Multi-Drug-Resistant Gram-Negative Bacteria Using In Silico Modelling

  2022cites this paper
• An Update on Eight “New” Antibiotics against Multidrug-Resistant Gram-Negative Bacteria

  2021cites this paper
• Activity of temocillin against ESBL-, AmpC-, and/or KPC-producing Enterobacterales isolated in Poland

  2020cites this paper
• Evaluation of Antimicrobial Effects of a New Polymyxin Molecule (SPR741) When Tested in Combination with a Series of β-Lactam Agents Against a Challenge Set of Gram-Negative Pathogens

  2020influential citation
• Prevalence of Diabetes Mellitus and Clinicodemographic Profiles of Patients with Head and Neck Infections in a Philippine Tertiary Government Hospital

  2020cites this paper
• Activity of temocillin and comparators against urinary Escherichia coli and Klebsiella pneumoniae from Iran

  2020cites this paper
• Activity of temocillin against KPC-producing Enterobacteriaceae clinical isolates recovered in Greek hospitals.

  2019cites this paper
• Hypervirulence and carbapenem resistance: two distinct evolutionary directions that led high-risk Klebsiella pneumoniae clones to epidemic success

  2019cites this paper
• Antimicrobial Activity and Biochemical Profiling of Selected Medicinal Plants against Blood Cancer Clinical Isolates

  2018cites this paper
• Pharmacokinetics and Pharmacodynamics of Temocillin

  2018cites this paper
• Treatment of infections caused by multidrug-resistant Gram-negative bacteria: report of the British Society for Antimicrobial Chemotherapy/Healthcare Infection Society/British Infection Association Joint Working Party†

  2018cites this paper
• Treatment of Infections Caused by Extended-Spectrum-Beta-Lactamase-, AmpC-, and Carbapenemase-Producing Enterobacteriaceae

  2018cites this paper
• Epidemiology and resistance phenotypes of carbapenemase-producing Klebsiella pneumoniae in Greece, 2014 to 2016

  2018cites this paper
• Prostate biopsy related infection – risk factors, prevention strategies and management approaches

  2018cites this paper
• Prostate Biopsy-related Infection: A Systematic Review of Risk Factors, Prevention Strategies, and Management Approaches.

  2017cites this paper
• Prevalence and molecular characterization of extended spectrum Beta-Lactamase producing multidrug-resistant Pseudomonas aeruginosa and Klebsiella pneumoniae isolates

  2017cites this paper
• « Nouvelles » molécules anti-infectieuses. Quelle place en médecine intensive/réanimation pour ceftolozane–tazobactam et la témocilline ?

  2017cites this paper
• Isolation and Identification of Multidrug Resistant Klebsiella Spp . Causing Urinary Tract Infections

  2017cites this paper
• Virulence factors and antibiotic susceptibility patterns of Klebsiella pneumonia strains Histamine producing bacteria isolated from sputum

  2017cites this paper
• Role of old antimicrobial agents in the management of urinary tract infection

  2016cites this paper
• Global Dissemination of Carbapenemase-Producing Klebsiella pneumoniae: Epidemiology, Genetic Context, Treatment Options, and Detection Methods

  2016cites this paper
• Activity of temocillin in a lethal murine model of infection of intra-abdominal origin due to KPC-producing Escherichia coli.

  2016cites this paper
• Coproduction of KPC-18 and VIM-1 Carbapenemases by Enterobacter cloacae : Implications for Newer (cid:2) -Lactam– (cid:2) -Lactamase Inhibitor Combinations

  2016cites this paper
• UKCPA Pharmacy Infection Network Carbapenamase producing Enterobacteriaceae ( CPE ) treatment guidance Acknowledgements

  2016cites this paper
• Temocillin (6 g daily) in critically ill patients: continuous infusion versus three times daily administration.

  2015cites this paper
• Diagnosis and antimicrobial treatment of invasive infections due to multidrug-resistant Enterobacteriaceae. Guidelines of the Spanish Society of Infectious Diseases and Clinical Microbiology.

  2015cites this paper
• Activity of temocillin, mecillinam, ceftazidime, and ceftazidime/avibactam against carbapenem-non-susceptible Enterobacteriaceae without carbapenemase production

  2015cites this paper
• Carbapenemase-Producing Klebsiella pneumoniae, a Key Pathogen Set for Global Nosocomial Dominance

  2015cites this paper
• Coproduction of KPC-18 and VIM-1 Carbapenemases by Enterobacter cloacae: Implications for Newer β-Lactam–β-Lactamase Inhibitor Combinations

  2015cites this paper
• Treatment of infections caused by carbapenemase-producing Enterobacteriaceae.

  2014cites this paper
• Multidrug-resistant and extensively drug-resistant Gram-negative pathogens: current and emerging therapeutic approaches

  2014influential citation
• Biliary pharmacodynamic exposure to linezolid in two liver transplant patients.

  2014cites this paper
• Therapy of Infections due to Carbapenem-Resistant Gram-Negative Pathogens

  2014cites this paper
• In vitro Temocillin efficacy against extended spectrum β-lactamase producing multidrug resistant gram negative bacterial isolates from Nepal.

  2014influential citation
• In vitro activity of temocillin against multidrug-resistant clinical isolates of Escherichia coli, Klebsiella spp. and Enterobacter spp., and evaluation of high-level temocillin resistance as a diagnostic marker for OXA-48 carbapenemase.

  2014cites this paper
• A new strategy to fight antimicrobial resistance: the revival of old antibiotics

  2014cites this paper
• Clinical epidemiology of the global expansion of Klebsiella pneumoniae carbapenemases.

  2013cites this paper
• Témocilline, une alternative aux carbapénèmes pour traiter les infections à entérobactéries résistantes aux C3G ?

  2013cites this paper
• Crisis of Global Dimensions and Other Enterobacteriaceae: an Evolving Carbapenemases in Klebsiella pneumoniae

  2012influential citation
• Carbapenemases in Klebsiella pneumoniae and Other Enterobacteriaceae: an Evolving Crisis of Global Dimensions

  2012influential citation
• Plasmid-Mediated Resistance in Enterobacteriaceae

  2012cites this paper
• When and How to Cover for Resistant Gram-Negative Bacilli in Severe Sepsis and Septic Shock

  2011cites this paper
• Prevalence of Antimicrobial Drug Resistance of Klebsiella pneumoniae in India

  2011cites this paper
• What remains against carbapenem-resistant Enterobacteriaceae? Evaluation of chloramphenicol, ciprofloxacin, colistin, fosfomycin, minocycline, nitrofurantoin, temocillin and tigecycline.

  2011cites this paper
• Challenge to healthcare: Multidrug resistance in Klebsiella pneumoniae

  2011cites this paper
• Klebsiella has taken lead among uropathogens in University of Benin Teaching Hospital, Benin City, Nigeria-An observation

  2010cites this paper
• Klebsiella sp has taken lead among uropathogens in outpatients of University of Benin Teaching Hospital, Benin City. Nigeria-An observation

  2010cites this paper
• β-Lactam antibiotics

  2010cites this paper
• Global spread of multidrug-resistant gram-negative bacilli

  2010cites this paper
• Quelles nouveautés en antibiothérapie

  2010cites this paper
• [Update on antimicrobial chemotherapy].

  2010cites this paper